Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Vivek
May 25, 2024, 12:41 |
Insight
Vivek Subbiah: KRAS inhibitors are here to stay
Vivek Subbiah shared on X: “KRAS inhibitors are here ASCO24 & here to stay for all…
May 25, 2024, 11:59 |
Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 25, 2024, 08:27 |
Blog
Vivek Subbiah: Thank you to the OncoDaily team for the esteemed 'Voice of Oncology Award' at ASCO 2024
Vivek Subbiah shared a post by OncoDaily on LinkedIn, adding: "Gratitude overload! Sending a heartfelt…
May 24, 2024, 00:42 |
Societies
Vivek Subbiah wholeheartedly supports and endorses Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "Exciting news! The elections for the ESMO President 2027-2028 are…
May 22, 2024, 08:29 |
Blog
Vivek Subbiah: Let's celebrate the power of research and the hope
Vivek Subbiah shared on LinkedIn: "On this Clinical Trials Day, I’m immensely grateful for the incredible…
May 19, 2024, 15:15 |
Insight
Vivek Subbiah: Precision Oncology NTRK - How to you pick needles from the haystack?
Vivek Subbiah shared on LinkedIn: "Pleased to share our editorial American Cancer Society Journal Cancer. TRKing…
May 18, 2024, 09:18 |
Blog
Vivek Subbiah: KRAS inhibition reminds me of this Greek restaurant KRASi in Boston
Vivek Subbiah shared a post on X/Twitter: ''Pleased to share our editorial in an ASCO journal.…
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
May 15, 2024, 11:55 |
Blog
Vivek Subbiah: Our editorial on the Mission to Target KRAS in Colorectal Cancer
Vivek Subbiah shared a post on LinkedIn: "Delighted to share our editorial - just published in…
May 14, 2024, 13:12 |
Opinion
Vivek Subbiah: Statisticians: Are you a frequentist or Bayesian?
Vivek Subbiah shared a post on LinkedIn: "Statisticians: Are you a frequentist or Bayesian? Me: I'm…
3
4
5
6
7
All:
301
Posts:
41 - 50
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Facebook
RSS Feed
Twitter
Linkedin
Youtube